Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000035

President and CEO sold 41,070 shares at an average $1.13 ($46,501)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2023-01-04 Sale −27,549 $1.13 $31,232 799,534 D: show line 1 in the form
Brunn Carsten President and CEO 2023-01-04 Sale −48 $1.15 $55 799,486 D: show line 2 in the form
Brunn Carsten President and CEO 2023-01-05 Sale −13,396 $1.13 $15,128 786,090 D: show line 3 in the form
Brunn Carsten President and CEO 2023-01-05 Sale −77 $1.12 $86 786,013 D: show line 4 in the form
Open-market sales · 41,070 sh · avg $1.13 · $46,501
Loading xslF345X03/wf-form4_167304337502065.xml…